中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2014年
44期
3497-3500
,共4页
李明%Takehiro Izumo%张国良%彭爱梅%王昌惠
李明%Takehiro Izumo%張國良%彭愛梅%王昌惠
리명%Takehiro Izumo%장국량%팽애매%왕창혜
肺肿瘤%支气管镜检查%窄谱成像%肿瘤浸润%肿瘤治疗方案
肺腫瘤%支氣管鏡檢查%窄譜成像%腫瘤浸潤%腫瘤治療方案
폐종류%지기관경검사%착보성상%종류침윤%종류치료방안
Lung neoplasms%Bronchoscopy%Narrow band imaging%Tumor-infiltrating%Antineoplastic protocols
目的:评价窄谱成像( NBI)支气管镜对评估中央型肺癌浸润范围及制定治疗方案的价值。方法使用日本奥林巴斯公司的EVIS LUCERA光谱支气管镜,对2012年6月至2014年6月上海市第十人民医院符合入选标准的患者进行白光支气管镜( WLB)和NBI检查,统计并比较两种方法镜下肿瘤浸润范围、阳性表现和病理学结果。结果共196例患者入选,男152例,女44例,年龄(58±10)岁。分析确诊中央型肺癌的168例患者中,NBI 发现22例(13.1%)的肺癌浸润范围比WLB更广( NBI下浸润比WLB下>1 cm),其中19例(占肺癌患者的11.3%)改变治疗方案,包括改变手术方式14例,终止手术5例。多因素回归分析显示,病灶≥30 mm和病理类型为鳞癌为2个独立的预测因素,此类患者使用NBI评估肿瘤浸润范围较WLB更广的比例更高( OR=3.13,95% CI:1.06~9.21, P=0.038;OR=4.68,95% CI:1.02~21.58, P=0.048);NBI和WLB诊断肺癌敏感度、特异度、阳性预测值、阴性预测值分别为88.2%、83.3%、98.1%、41.7%和80.3%、55.6%、94.7%、22.2%。结论临床上使用NBI利于早期中央型肺癌的诊断,便于更准确的判断肺癌的浸润范围,帮助临床医师制定最佳的治疗方案。
目的:評價窄譜成像( NBI)支氣管鏡對評估中央型肺癌浸潤範圍及製定治療方案的價值。方法使用日本奧林巴斯公司的EVIS LUCERA光譜支氣管鏡,對2012年6月至2014年6月上海市第十人民醫院符閤入選標準的患者進行白光支氣管鏡( WLB)和NBI檢查,統計併比較兩種方法鏡下腫瘤浸潤範圍、暘性錶現和病理學結果。結果共196例患者入選,男152例,女44例,年齡(58±10)歲。分析確診中央型肺癌的168例患者中,NBI 髮現22例(13.1%)的肺癌浸潤範圍比WLB更廣( NBI下浸潤比WLB下>1 cm),其中19例(佔肺癌患者的11.3%)改變治療方案,包括改變手術方式14例,終止手術5例。多因素迴歸分析顯示,病竈≥30 mm和病理類型為鱗癌為2箇獨立的預測因素,此類患者使用NBI評估腫瘤浸潤範圍較WLB更廣的比例更高( OR=3.13,95% CI:1.06~9.21, P=0.038;OR=4.68,95% CI:1.02~21.58, P=0.048);NBI和WLB診斷肺癌敏感度、特異度、暘性預測值、陰性預測值分彆為88.2%、83.3%、98.1%、41.7%和80.3%、55.6%、94.7%、22.2%。結論臨床上使用NBI利于早期中央型肺癌的診斷,便于更準確的判斷肺癌的浸潤範圍,幫助臨床醫師製定最佳的治療方案。
목적:평개착보성상( NBI)지기관경대평고중앙형폐암침윤범위급제정치료방안적개치。방법사용일본오림파사공사적EVIS LUCERA광보지기관경,대2012년6월지2014년6월상해시제십인민의원부합입선표준적환자진행백광지기관경( WLB)화NBI검사,통계병비교량충방법경하종류침윤범위、양성표현화병이학결과。결과공196례환자입선,남152례,녀44례,년령(58±10)세。분석학진중앙형폐암적168례환자중,NBI 발현22례(13.1%)적폐암침윤범위비WLB경엄( NBI하침윤비WLB하>1 cm),기중19례(점폐암환자적11.3%)개변치료방안,포괄개변수술방식14례,종지수술5례。다인소회귀분석현시,병조≥30 mm화병리류형위린암위2개독립적예측인소,차류환자사용NBI평고종류침윤범위교WLB경엄적비례경고( OR=3.13,95% CI:1.06~9.21, P=0.038;OR=4.68,95% CI:1.02~21.58, P=0.048);NBI화WLB진단폐암민감도、특이도、양성예측치、음성예측치분별위88.2%、83.3%、98.1%、41.7%화80.3%、55.6%、94.7%、22.2%。결론림상상사용NBI리우조기중앙형폐암적진단,편우경준학적판단폐암적침윤범위,방조림상의사제정최가적치료방안。
Objective To determine the sensitivity of narrow-band imaging bronchoscopy ( NBI) in the assessment of tumor extent and therapeutic strategy .Methods A total of 196 patients with imaging abnormalities for malignancy were examined with both white light bronchoscopy (WLB) and NBI (Olympus, EVIS LUCERA).Record the tumor infiltration , image and pathological results .Results There were 152 male and 44 female with a mean age of 58 years.In 22 patients ( 13.1%) , NBI revealed greater tumor extent than WLB alone.And tumor margins were >1 cm wider on NBI examination than on WLB .In 19 patients (11.3%), that finding influenced further therapeutic course , leading to greater resection level (n=14) or avoidance of surgery (n=5).According to univariate analysis, tumor size >30 mm and pathological type of squamous cell carcinoma were independent predictive factors ( OR 3.13, 95% CI:1.06-9.21, P=0.038;OR 4.68, 95%CI:1.02-21.58, P=0.048).The diagnostic sensitivity of NBI group was 88.2%, specificity 83.3%, positive predictive value 98.1%and false predictive value 41.7%. And the diagnostic sensitivity of WLB group was 80.3%, specificity 55.6%, positive predictive value 94.7%and false predictive value 22.2%.Conclusions The combined use of NBI bronchoscopy and conventional white-light examination has greater sensitivity and specificity for assessing tumor margins .And this technique also significantly improves the assessment of central lung cancer infiltration and influences the therapeutic strategy.